Literature DB >> 14499791

Physician-reported reasons for limited follow-up of patients with a positive fecal occult blood test screening result.

Nadeem Baig1, Ronald E Myers, Barbara J Turner, James Grana, Todd Rothermel, Neil Schlackman, David S Weinberg.   

Abstract

OBJECTIVE: Fecal occult blood testing (FOBT) screening can reduce colorectal cancer (CRC) mortality when patients with an abnormal result [FOBT(+)] undergo a complete diagnostic evaluation (colonoscopy or double-contrast barium enema with or without flexible sigmoidoscopy). The aim of this study was to determine common reasons for nonperformance of a complete diagnostic evaluation.
METHODS: We identified 544 FOBT(+) patients, aged 50 yr or older, who had participated in a managed care organization-sponsored CRC screening program. The performance of a complete diagnostic evaluation was determined from a patient-specific follow-up form and managed care organization claims data. Physicians were asked to report whether patients submitted to a complete diagnostic evaluation. When an evaluation was not done, the physicians were also asked to state the reasons for nonperformance.
RESULTS: A total of 248 (46%) patients did not undergo a complete diagnostic evaluation. Physicians provided reasons for nonperformance for 50% (123/248). Factors accounting for nonperformance of a complete diagnostic evaluation were classified as follows: primary care physician decision (50%); specialist decision (28%); patient decision (17%); and other (practice-related) (5%). Many failures to complete an appropriate diagnostic evaluation were due to providers deciding to repeat the FOBT, perform a sigmoidoscopy, or not to proceed with any further testing.
CONCLUSION: Many patients with a positive FOBT do not receive a complete diagnostic evaluation. The reasons for nonperformance most frequently have to do with physician decision making. Many physician-related explanations do not conform to expert recommendations for appropriate follow-up.

Entities:  

Mesh:

Year:  2003        PMID: 14499791     DOI: 10.1111/j.1572-0241.2003.07575.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  32 in total

1.  Effectiveness of complete diagnostic examination in clinical practice settings.

Authors:  Masahito Jimbo; Birgit Meyer; Terry Hyslop; James Cocroft; Barbara J Turner; David S Weinberg; Ronald E Myers
Journal:  Cancer Detect Prev       Date:  2006-11-17

2.  Effectiveness of a provider reminder on fecal occult blood test follow-up.

Authors:  Meaghan F Larson; Cynthia W Ko; Jason A Dominitz
Journal:  Dig Dis Sci       Date:  2009-03-03       Impact factor: 3.199

3.  Results of the national lung cancer screening trial: where are we now?

Authors:  Neel P Chudgar; Peter R Bucciarelli; Elizabeth M Jeffries; Nabil P Rizk; Bernard J Park; Prasad S Adusumilli; David R Jones
Journal:  Thorac Surg Clin       Date:  2015-02-02       Impact factor: 1.750

4.  Inadequate Utilization of Diagnostic Colonoscopy Following Abnormal FIT Results in an Integrated Safety-Net System.

Authors:  Rachel B Issaka; Maneesh H Singh; Sachiko M Oshima; Victoria J Laleau; Carly D Rachocki; Ellen H Chen; Lukejohn W Day; Urmimala Sarkar; Ma Somsouk
Journal:  Am J Gastroenterol       Date:  2016-12-13       Impact factor: 10.864

Review 5.  CT colonography: role in FOBT-based screening programs for colorectal cancer.

Authors:  Lapo Sali; Grazia Grazzini; Mario Mascalchi
Journal:  Clin J Gastroenterol       Date:  2017-04-26

6.  Patient and physician reminders to promote colorectal cancer screening: a randomized controlled trial.

Authors:  Thomas D Sequist; Alan M Zaslavsky; Richard Marshall; Robert H Fletcher; John Z Ayanian
Journal:  Arch Intern Med       Date:  2009-02-23

7.  Diagnostic resolution of cancer screening abnormalities at community health centers.

Authors:  Richard G Roetzheim; Ji-Hyun Lee; Ercilia R Calcano; Cathy D Meade; William J Fulp; Kristen J Wells
Journal:  J Health Care Poor Underserved       Date:  2012-08

8.  Using a multifaceted approach to improve the follow-up of positive fecal occult blood test results.

Authors:  Hardeep Singh; Himabindu Kadiyala; Gayathri Bhagwath; Anila Shethia; Hashem El-Serag; Annette Walder; Maria E Velez; Laura A Petersen
Journal:  Am J Gastroenterol       Date:  2009-03-17       Impact factor: 10.864

9.  Acceptance of colonoscopy requires more than test tolerance.

Authors:  Amanda Condon; Lesley Graff; Lawrence Elliot; Alexandra Ilnyckyj
Journal:  Can J Gastroenterol       Date:  2008-01       Impact factor: 3.522

10.  Improving follow-up of abnormal cancer screens using electronic health records: trust but verify test result communication.

Authors:  Hardeep Singh; Lindsey Wilson; Laura A Petersen; Mona K Sawhney; Brian Reis; Donna Espadas; Dean F Sittig
Journal:  BMC Med Inform Decis Mak       Date:  2009-12-09       Impact factor: 2.796

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.